SG11201507264YA - Thermostable blunt-end ligase and methods of use - Google Patents

Thermostable blunt-end ligase and methods of use

Info

Publication number
SG11201507264YA
SG11201507264YA SG11201507264YA SG11201507264YA SG11201507264YA SG 11201507264Y A SG11201507264Y A SG 11201507264YA SG 11201507264Y A SG11201507264Y A SG 11201507264YA SG 11201507264Y A SG11201507264Y A SG 11201507264YA SG 11201507264Y A SG11201507264Y A SG 11201507264YA
Authority
SG
Singapore
Prior art keywords
methods
thermostable blunt
end ligase
ligase
thermostable
Prior art date
Application number
SG11201507264YA
Other languages
English (en)
Inventor
Frederick Christians
Original Assignee
Theranos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theranos Inc filed Critical Theranos Inc
Publication of SG11201507264YA publication Critical patent/SG11201507264YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y605/00—Ligases forming phosphoric ester bonds (6.5)
    • C12Y605/01—Ligases forming phosphoric ester bonds (6.5) forming phosphoric ester bonds (6.5.1)
    • C12Y605/01001—DNA ligase (ATP) (6.5.1.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SG11201507264YA 2013-03-15 2014-03-15 Thermostable blunt-end ligase and methods of use SG11201507264YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361802124P 2013-03-15 2013-03-15
PCT/US2014/030003 WO2014145269A1 (fr) 2013-03-15 2014-03-15 Ligase à extrémité franche thermostable et procédés d'utilisation

Publications (1)

Publication Number Publication Date
SG11201507264YA true SG11201507264YA (en) 2015-10-29

Family

ID=51528783

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201507264YA SG11201507264YA (en) 2013-03-15 2014-03-15 Thermostable blunt-end ligase and methods of use

Country Status (9)

Country Link
US (4) US9273301B2 (fr)
EP (2) EP2970922B1 (fr)
AU (1) AU2014233213A1 (fr)
CA (1) CA2903873C (fr)
ES (2) ES2904847T3 (fr)
IL (1) IL241073B (fr)
PL (1) PL2970922T3 (fr)
SG (1) SG11201507264YA (fr)
WO (1) WO2014145269A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2904847T3 (es) 2013-03-15 2022-04-06 Labrador Diagnostics Llc Ligasa de extremos romos termostable y métodos de uso
JP2016521120A (ja) 2013-03-15 2016-07-21 セラノス， インコーポレイテッド 核酸増幅
CA2921226A1 (fr) 2013-09-06 2015-03-12 Theranos, Inc. Dispositifs, systemes, procedes et kits de reception d'un ecouvillon
EP3277837A1 (fr) * 2015-03-31 2018-02-07 Qiagen GmbH Procédés de ligature avec efficacité améliorée
KR20200003903A (ko) * 2017-05-08 2020-01-10 코덱시스, 인코포레이티드 조작된 리가제 변이체
CN108220255B (zh) * 2017-09-24 2021-03-16 天津强微特生物科技有限公司 一种嗜热古细菌的高活性dna连接酶突变体
US10837009B1 (en) 2017-12-22 2020-11-17 New England Biolabs, Inc. DNA ligase variants
WO2020124319A1 (fr) * 2018-12-17 2020-06-25 深圳华大生命科学研究院 Protéine de fusion et son application

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5700672A (en) * 1992-07-23 1997-12-23 Stratagene Purified thermostable pyrococcus furiousus DNA ligase
ES2393056T3 (es) 1998-11-09 2012-12-18 Eiken Kagaku Kabushiki Kaisha Procedimiento de síntesis de ácido nucleico
WO2005047547A1 (fr) 2003-11-04 2005-05-26 Applera Corporation Compositions procedes et necessaires pour la formation de produits de ligature concatemeriques
JP4486009B2 (ja) 2005-08-10 2010-06-23 株式会社日立製作所 Ｄｎａリガーゼ変異体
DK2205968T3 (en) 2007-10-02 2014-02-17 Theranos Inc Modular POC (point of care) Devices and uses thereof
CN102597006A (zh) * 2009-09-16 2012-07-18 梅西大学 融合多肽以及其应用
US8380541B1 (en) 2011-09-25 2013-02-19 Theranos, Inc. Systems and methods for collecting and transmitting assay results
ES2904847T3 (es) 2013-03-15 2022-04-06 Labrador Diagnostics Llc Ligasa de extremos romos termostable y métodos de uso
US9416387B2 (en) * 2013-03-15 2016-08-16 Theranos, Inc. Nucleic acid amplification
BR112016011692A2 (pt) * 2013-11-22 2017-09-26 Theranos Inc amplificação de ácido nucléico

Also Published As

Publication number Publication date
CA2903873C (fr) 2023-09-05
US20160186164A1 (en) 2016-06-30
EP2970922A4 (fr) 2016-10-12
US9719081B2 (en) 2017-08-01
ES2904847T3 (es) 2022-04-06
CA2903873A1 (fr) 2014-09-18
EP3360958B1 (fr) 2021-12-22
US20170298338A1 (en) 2017-10-19
US9273301B2 (en) 2016-03-01
AU2014233213A1 (en) 2015-09-17
US20170015989A1 (en) 2017-01-19
IL241073B (en) 2018-08-30
ES2661662T3 (es) 2018-04-03
EP2970922A1 (fr) 2016-01-20
IL241073A0 (en) 2015-11-30
EP2970922B1 (fr) 2017-12-13
WO2014145269A1 (fr) 2014-09-18
US20140273102A1 (en) 2014-09-18
PL2970922T3 (pl) 2018-06-29
EP3360958A1 (fr) 2018-08-15

Similar Documents

Publication Publication Date Title
HUS2200048I1 (hu) FcRn antagonisták és alkalmazásaik
HRP20170840T1 (hr) Supstituirani ksantini i metode njihove uporabe
HK1217428A1 (zh) 取代的苯並噁唑及其使用方法
HK1223913A1 (zh) 經取代的苯甲酰胺及其使用方法
SG11201600028YA (en) Substituted aminopyrimidine compounds and methods of use
IL241073A0 (en) Thermally stable ligase with smooth ends and methods of use
IL244268A0 (en) Heterocyclic compounds and methods of use
PL3019477T3 (pl) Związki heterocykliczne i sposoby ich stosowania
IL245272A0 (en) pif-transfected cells and methods of use
SG11201507389RA (en) Integration of hydro-dechlorination and hydro-regeneration
GB201310349D0 (en) Composition and method of use thereof
GB201301928D0 (en) Composition and method of use thereof